The Hungarian pharmaceutical company Gideon Richter has agreed to acquire the Australian Maine Pharma for 604 million Australian dollars (about 407.8 million US dollars), reports Reuters. The buyer offered A$6.40 per share, a 99.4% premium to the previous close, sending Maine's share price up 86% to a one-year high. The deal is subject to regulatory approval and the completion of the sale of Maine's international business to Auris Pharma.